You are Here
N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions
Peptides Uncategorized

N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions

Pancreatic stellate cells (PSCs) occupy the vast majority of the pancreatic most cancers microenvironment, contributing to aggressive conduct of pancreatic most cancers cells (PCCs). Not too long ago, anti-fibrotic brokers have confirmed to be an efficient technique in opposition to most cancers, however medical trials have proven little efficacy, and the driving mechanism stays unknown. N-acetyl-cysteine (NAC) is usually used for pulmonary cystic fibrosis. Pioglitazone, an agonist of peroxisome proliferator-activated receptor gamma, was habitually used for kind II diabetes, however lately reported to inhibit metastasis of PCCs. Nonetheless, few research have centered on the results of those two brokers on most cancers-stromal interactions.
We evaluated the expression of α-smooth muscle actin (α-SMA) and the variety of lipid droplets in PSCs cultured with or with out NAC. We additionally evaluated modifications in invasiveness, viability, and oxidative degree in PSCs and PCCs after NAC remedy. Utilizing an oblique co-culture system, we investigated modifications in viability, invasiveness, and migration of PSCs and PCCs. Mixed remedy results of NAC and Pioglitazone have been evaluated in PSCs and PCCs. In vivo, we co-transplanted KPC-derived organoids and PSCs to guage the results of NAC and Pioglitazone’s mixture remedy on subcutaneous tumor formation and splenic xenografted mouse fashions.
In vitro, NAC inhibited the viability, invasiveness, and migration of PSCs at a low focus, however not these of PCCs. NAC remedy considerably lowered oxidative stress degree and expression of α-SMA, collagen kind I in PSCs, which apparently current a quiescent-like state with a excessive variety of lipid droplets. Co-cultured PSCs and PCCs mutually promoted the viability, invasiveness, and migration of one another. Nonetheless, these promotion results have been attenuated by NAC remedy. Pioglitazone maintained the NAC-induced quiescent-like state of PSCs, which have been reactivated by PCC-supernatant, and enhanced chemosensitivity of PCCs. In vivo, NAC and Pioglitazone’s mixture suppressed tumor development and liver metastasis with fewer stromal elements and oxidative stress degree.

CSE1L, as a novel prognostic marker, promotes pancreatic most cancers proliferation by regulating the AKT/mTOR signaling pathway

Pancreatic most cancers is among the most aggressive tumors with poor prognosis and new targetable therapies are urgently required. CSE1L (chromosome segregation 1 like) is assumed to play an necessary function in tumorigenesis and acts as a most cancers therapeutic goal. Nonetheless, the organic operate and the underlying mechanism of CSE1L in pancreatic most cancers are nonetheless not totally specific. Within the current examine, we discovered that prime CSE1L expression was associated to a worse prognosis in sufferers with pancreatic most cancers in line with information from the Most cancers Genome Atlas (TCGA) database.

Moreover, we discovered that CSE1L knockdown inhibited the proliferation of pancreatic most cancers cells and promoted apoptosis, whereas CSE1L overexpression demonstrated the other phenomenon. Moreover, we found that CSE1L may regulate pancreatic most cancers proliferation by AKT signaling pathway. In abstract, we reveal that CSE1L performs a vital function in tumor development and should function a possible prognostic and therapeutic goal for pancreatic most cancers. PubMed and the Cochrane Library database have been looked for VOC evaluation research

wherein exhaled air was used to detect gastro-oesophageal, liver, pancreatic, and intestinal most cancers in people, High quality evaluation was carried out utilizing the QUADAS-2 standards. Information on diagnostic efficiency, VOCs with discriminative energy, and methodological data have been extracted from the included articles. The literature on VOC evaluation has documented a scarcity of standardization in examine designs. Heterogeneity between the research and inadequate validation of the outcomes make interpretation of the outcomes difficult. To achieve medical applicability, future research on breath evaluation ought to present an correct description of the methodology and validate their findings.

N-acetyl cysteine induces quiescent-like pancreatic stellate cells from an active state and attenuates cancer-stroma interactions

Girdin Knockdown Will increase Gemcitabine Chemosensitivity to Pancreatic Most cancers by Modulating Autophagy

Chemotherapy is essential for the remedy of pancreatic most cancers (PC). Gemcitabine (GEM) because the first-line chemotherapy drug has a excessive resistance charge. Rising the sensitivity of gemcitabine is at present the goals and challenges of this examine. Our earlier examine confirmed Girdin was intently associated to the development and prognosis of PC, indicating that Girdin could also be related to chemosensitivity. Within the present examine, we use recombinant adenovirus to particularly knockdown Girdin in PC cell traces to find out the impact of Girdin within the technique of gemcitabine chemosensitivity.

Autophagy is among the pathways affecting the gemcitabine chemosensitivity in PC. Additional analysis validated that Girdin might activate autophagy by interacting with autophagy protein p62/SQSTM1, which may improve chemotherapy resistance to gemcitabine in PC. Down-regulation of Girdin might due to this fact improve gemcitabine chemosensitivity in PC. Our outcomes reveal that Girdin acted as a destructive regulator of gemcitabine chemosensitivity in PC.

Elevated autophagy exercise brought on by abnormally excessive Girdin expression could also be one of many principal elements for the discount in chemosensitivity, which can present new views on understanding chemosensitization in PC. Tumor molecular profile evaluation by Subsequent Technology Sequencing know-how is at present broadly utilized in medical apply and has enabled the detection of predictive biomarkers of response to focused remedy. In parallel with focused therapies, immunotherapies are additionally evolving, revolutionizing most cancers remedy, with Programmed Loss of life-ligand 1 (PD-L1), Microsatellite instability (MSI), and Tumor Mutational Burden (TMB) evaluation being the biomarkers employed mostly.

Human Lung cancer marker ELISA kit
E01L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Lung cancer marker ELISA kit
E01L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human lung cancer Marker ELISA Kit
GA-E1674HM-48T 48T
EUR 346.8

Human lung cancer Marker ELISA Kit
GA-E1674HM-96T 96T
EUR 559.2

Human Lung cancer marker ELISA Kit
EHL0303 96Tests
EUR 625.2

Human lung cancer Marker ELISA Kit
QY-E03612 96T
EUR 480

human lung cancer Marker ELISA Kit
YLA2705HU-48T 48T
EUR 435

human lung cancer Marker ELISA Kit
YLA2705HU-96T 96T
EUR 562.5

Dog Lung cancer marker ELISA kit
E08L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Lung cancer marker ELISA kit
E08L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Lung cancer marker ELISA kit
E08L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Canine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Lung cancer marker ELISA Kit
ERL0303 96Tests
EUR 625.2

Rat Lung cancer marker ELISA kit
E02L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Lung cancer marker ELISA kit
E02L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Lung cancer marker ELISA kit
E02L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Lung cancer marker ELISA kit
E07L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Lung cancer marker ELISA kit
E07L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Lung cancer marker ELISA kit
E07L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Porcine Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Lung cancer marker ELISA kit
E06L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Lung cancer marker ELISA kit
E06L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Lung cancer marker ELISA kit
E06L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Goat Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Lung cancer marker ELISA Kit
EGTL0303 96Tests
EUR 625.2

Mouse Lung cancer marker ELISA Kit
EML0303 96Tests
EUR 625.2

Mouse Lung cancer marker ELISA kit
E03L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Lung cancer marker ELISA kit
E03L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Mouse Lung cancer marker ELISA kit
E03L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Mouse Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Canine Lung cancer marker ELISA Kit
ECL0303 96Tests
EUR 625.2

Rabbit Lung cancer marker ELISA Kit
ERTL0303 96Tests
EUR 625.2

Rabbit Lung cancer marker ELISA kit
E04L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Lung cancer marker ELISA kit
E04L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rabbit Lung cancer marker ELISA kit
E04L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Rabbit Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Lung cancer marker ELISA kit
E09L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Lung cancer marker ELISA kit
E09L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Monkey Lung cancer marker ELISA kit
E09L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Monkey Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Bovine Lung cancer marker ELISA Kit
EBL0303 96Tests
EUR 625.2

Porcine Lung cancer marker ELISA Kit
EPL0303 96Tests
EUR 625.2

Anserine Lung cancer marker ELISA Kit
EAL0303 96Tests
EUR 625.2

Guinea pig Lung cancer marker ELISA kit
E05L0296-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Lung cancer marker ELISA kit
E05L0296-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea pig Lung cancer marker ELISA kit
E05L0296-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Guinea pig Lung cancer marker in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Guinea Pig Lung cancer marker ELISA Kit
EGL0303 96Tests
EUR 625.2

Human tumor marker DR- 70 for lung cancer ELISA Kit
ELA-E1259h 96 Tests
EUR 988.8

Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit
201-12-1679 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit
GA-E1695HM-48T 48T
EUR 346.8

Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit
GA-E1695HM-96T 96T
EUR 559.2

Human DR-70TM(Tumor Marker DR-70 For Lung Cancer) ELISA Kit
EH2961 96T
EUR 628.92
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ug/ml

Human tumor marker DR-70 for lung cancer(DR-70TM)ELISA Kit
QY-E03613 96T
EUR 480

Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit
YLA2714HU-48T 48T
EUR 435

Human tumor marker DR-70 for lung cancer,DR-70TM ELISA Kit
YLA2714HU-96T 96T
EUR 562.5

ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM)
KTE62601-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM)
KTE62601-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Tumor marker DR-70 for lung cancer (DR-70TM)
KTE62601-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Tumor marker DR-70 for lung cancer (DR-70TM) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Lung cancer
LC751 each
EUR 234
Description: Lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 25 cases/75 cores (core size 1.5mm),Recent Year Collection

Lung Cancer Exosome
P141-LG - Ask for price

Lung cancer with matched cancer adjacent lung tissue array
LC481 each
EUR 168
Description: Lung cancer with matched cancer adjacent lung tissue array, including pathology grade, TNM and clinical stage, 12 cases/48 cores

Lung cancer with lung tissue array
LC1503 each
EUR 258
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma fererence AJCC 8th edition), 75 cases/150 cores, replacing LUC1503

Lung cancer with lung tissue array
LC483a each
EUR 168
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th version), 48 cases/48 cores, replacing LC483

Lung cancer with lung tissue array
LC8010 each
EUR 270
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 80 cases/80 cores, replacing LC801

Lung cancer with lung tissue array
T043b each
EUR 66
Description: Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T043a

Human Lung Cancer PCR Primer Library
HLUCPL-I 1 set
EUR 657.6

Colon cancer and lung cancer tissue array
CLC601 each
EUR 306
Description: Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores

Stomach cancer and lung cancer tissue array
SLC601 each
EUR 306
Description: Stomach cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores

Lung Cancer Exosome RNA
P241-LG - Ask for price

Lung cancer tissue array
NSC151 each
EUR 420
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores

Lung cancer tissue array
NSC153 each
EUR 420
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores

Lung cancer tissue array
NSC154 each
EUR 420
Description: Lung cancer tissue array, with ALK results,, 150 cases/150 cores

Lung cancer tissue array
NSC155 each
EUR 420
Description: Lung cancer tissue array, with ALK results, 150 cases/150 cores

Lung cancer tissue array
NSC156 each
EUR 420
Description: Lung cancer tissue array, 150 cases/150 cores

Lung cancer tissue array
NSC157 each
EUR 420
Description: Lung cancer tissue array, 150 cases/150 cores

Lung cancer tissue array
LC1261 each
EUR 354
Description: Lung cancer tissue array, including pathology grade, TNM, clinical stage and PD-L1 (Sp263) information, 63 cases/126 cores

Lung cancer tissue array
LC243 each
EUR 198
Description: Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores

Lung cancer tissue array
LC485 each
EUR 198
Description: Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores

Lung cancer tissue array
LUN703 each
EUR 198
Description: Lung cancer tissue array,including pathology grade and TNM,7 cases/70 cores (core size 1.5mm)

Lung cancer tissue array
LC726b each
EUR 222
Description: Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing LC726

Lung cancer tissue array
LC721 each
EUR 270
Description: Lung cancer tissue array, including TNM and pathology grade, 24 cases/72 cores

Lung cancer tissue array
VLC11 each
EUR 66
Description: Lung cancer tissue array, with TNM and grade info, 11 cases/11 cores

Lung cancer tissue array
VLC12b each
EUR 66
Description: Lung cancer tissue array, including pathology grade, TNM and clinical stage, 12 cases/12 cores, replacing VLC12a

Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC marker (CD70
LC2163 each
EUR 552
Description: Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC marker (CD70, MPO and PD-L1), including pathology grade, TNM and clinical stage, 108 cases/216 cores(1.0mm)

Lung cancer with lung tissue test array
T045f each
EUR 66
Description: Lung cancer with lung tissue test array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T045e

Lung cancer and normal lung tissue array
LC482 each
EUR 198
Description: Lung cancer and normal lung tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores

Lung cancer and normal lung tissue array
LC811a each
EUR 270
Description: Lung cancer and normal lung tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 core

Human ovarian cancer marker-CA125 ELISA Kit
201-12-1663 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human ovarian cancer marker-CA125 ELISA Kit
GA-E1679HM-48T 48T
EUR 346.8

Human ovarian cancer marker-CA125 ELISA Kit
GA-E1679HM-96T 96T
EUR 559.2

Human Ovarian cancer marker-CA125 ELISA Kit
EHO0345 96Tests
EUR 625.2

Human ovarian cancer marker-CA125 ELISA Kit
QY-E02224 96T
EUR 480

Multiple lung cancer with lung tissue array
LC813b each
EUR 270
Description: Multiple lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma and atypical carcinoid are referencing AJCC 8th version), 79 cases/80 cores, replacing LC813a

Non-small cell lung cancer
LC871 each
EUR 258
Description: Non-small cell lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 29 cases/87 cores (core size 1.5mm),Recent Year Collection

Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit
201-12-1726 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit
GA-E1742HM-48T 48T
EUR 346.8

Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit
GA-E1742HM-96T 96T
EUR 559.2

Human nonsmall cell lung cancer/Lung tumor Antigen(LTA)ELISA Kit
QY-E03620 96T
EUR 495.6

Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit
YLA2738HU-48T 48T
EUR 435

Human nonsmall cell lung cancer/Lung tumor Antigen,LTA ELISA Kit
YLA2738HU-96T 96T
EUR 562.5

Lung cancer test tissue array
T046a each
EUR 48
Description: Lung cancer test tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T046

Human Cancer PrimaCell11: Lung Tumor Cells
2-96034 1 Kit Ask for price

Human ovarian cancer marker-CA125(CA125)ELISA Kit
YLA1446HU-48T 48T
EUR 435

Human ovarian cancer marker-CA125(CA125)ELISA Kit
YLA1446HU-96T 96T
EUR 562.5

High-density lung cancer array
LC6161 each
EUR 954
Description: High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores

Human Kita-kyushu lung cancer antigen 1 (CT83)
1-CSB-EP711093HU
  • EUR 524.40
  • EUR 285.60
  • EUR 1852.80
  • EUR 783.60
  • EUR 1234.80
  • EUR 355.20
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in E.coli

Human Kita-kyushu lung cancer antigen 1 (CT83)
1-CSB-YP711093HU
  • EUR 604.80
  • EUR 318.00
  • EUR 2198.40
  • EUR 915.60
  • EUR 1459.20
  • EUR 400.80
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in Yeast

Human Kita-kyushu lung cancer antigen 1 (CT83)
1-CSB-MP711093HU
  • EUR 351.60
  • EUR 1155.60
  • EUR 490.80
  • EUR 860.40
  • 100ug
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Human Kita-kyushu lung cancer antigen 1(CT83) expressed in Mammalian cell

Multiple lung cancer tissue array
LC20813c each
EUR 546
Description: Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores, replacing LC120813b

Multiple lung cancer tissue array
LC20815a each
EUR 546
Description: Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma is referenced AJCC 8th version), 208 cases/208 cores, replacing LC20815

High-density lung cancer with lung tissue array
LC2085d each
EUR 546
Description: High-density lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 186 cases/208 cores, replacing LC2085c

Lung cancer and matched adjacent lung tissue array
LC486 each
EUR 168
Description: Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases/48 cores

Lung cancer progression tissue array
LC1005b each
EUR 270
Description: Lung cancer progression tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing LC1005a

Early stage of lung cancer with lung tissue array
LC820 each
EUR 306
Description: Early stage of lung cancer with lung tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

Lung cancer with lung tissue array (2015 WHOclassification)
LC243a each
EUR 198
Description: Lung cancer with lung tissue array (2015 WHOclassification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 2 serial sections, 24 cases/48 cores, replacing LC243

Lung cancer and normal tissue array
LC722 each
EUR 306
Description: Lung cancer and normal tissue array, with TNM and grade data, 24 cases/72 cores

Lung cancer with lung tissue array (2015 WHO classification)
LC1203A each
EUR 306
Description: Lung cancer with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 120 cases/120 cores, replacing BC041115d

Lung cancer tissue array with adjacent normal lung tissue
LC813a each
EUR 270
Description: Lung cancer tissue array with adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 78 cases/80 cores, replaced by LC813b

Lung cancer with matched adjacent and cancer adjacent tissue array
BC04022a each
EUR 168
Description: Lung cancer with matched adjacent and cancer adjacent tissue array, including TNM, clinical stage and pathology grade, 3 cores/case, replacing BC04022

Lung cancer tissue array (1 of 5)
LC20812a each
EUR 546
Description: Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases/208 cores replacing LC20812

Lung cancer tissue array (2 of 5)
LC20813 each
EUR 546
Description: Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases/208 cores, replaced by LC20813b

Lung cancer tissue array (4 of 5)
LC20815 each
EUR 546
Description: Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases/208 cores, replaced by LC20815a

Lung cancer tissue array (5 of 5)
LC20816 each
EUR 546
Description: Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores

Lung cancer tissue array (5 of 5)
LC20816a each
EUR 546
Description: Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores (cores size 1.0mm),replacing LC20816

Lung cancer tissue array with matched adjacent lung tissue
LC488 each
EUR 168
Description: Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases/48 cores

Cancer of the lung, 102 cases (1.5mm)
LUC1021 1
EUR 300
Description: Lung cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases with grading and TNM staging data.) tissues

Cancer of the lung, 228 cases (1.1mm)
LUC2281 1
EUR 552
Description: Lung cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human Ovarian cancer marker/Carbohydrate antigen 125 ELISA kit
E01O0338-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human Ovarian cancer marker/Carbohydrate antigen 125 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC markers (PD-L1
LC2162 each
EUR 546
Description: Non-small cell lung cancer NSCLC tissue array (all samples are from 2006 to 2012) with multiple IHC markers (PD-L1, ALK, ROS1+, LKB1, CD38, CD70, HLA1, MPO, CD3 and CD8, containing stained intensity, location and cell type), including pathology grade, TNM and clinical stage, 108 cases/216 cores (core size 1.0mm)

Tumor molecular profile evaluation utilizing NGS is a first-tier methodology for quite a lot of tumor sorts and gives necessary data for determination making within the remedy of most cancers sufferers. Importantly, simultaneous evaluation for focused remedy and immunotherapy biomarkers may result in higher tumor characterization and supply actionable data within the majority of sufferers.

Share
Facebook Twitter Pinterest Linkedin

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *